Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
Good Assays for Bad Immunogenicity
Avoid “Bad” Immunogenicity by Using Assays That Are More Sensitive and Can Adapt to Increasingly Complex and Specialized Drugs
For full access to this article login to GEN Select now.
MS Sample Prep–Challenges and Pitfalls
Quality Control and Rigorous Adherence to Analytical Standards Remain Paramount
- When members of the Metabolomics Society congregated in Boston recently for their fourth annual meeting, one topic that generated great interest was the problem of sample preparation for mass-spec analysis. While mass spec is playing an ever-expanding role in research, medicine, forensics, and industrial quality control, a major challenge ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.